Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy-Reference-Cited by-同舟云学术

Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy

Published:2024-05 Issue: Volume:392 Page:117504
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Rexhaj Emrush,Bär Sarah^ORCID,Soria Rodrigo,Ueki Yasushi,Häner Jonas D.,Otsuka Tatsuhiko,Kavaliauskaite Raminta,Siontis George CM.,Stortecky Stefan,Shibutani Hiroki,Spirk David,Engstrøm Thomas,Lang Irene,Morf Laura,Ambühl Maria,Windecker Stephan,Losdat Sylvain,Koskinas Konstantinos C.,Räber Lorenz^ORCID

Funder

Inselspital, Universitätsspital Bern

Publisher

Elsevier BV

Reference53 articles.

1. Current Understanding of Atherogenesis;Brown;Am. J. Med.,2017

2. Endothelial function and dysfunction: testing and clinical relevance;Deanfield;Circulation,2007

3. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans;Thijssen;Eur. Heart J.,2019

4. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery;Corretti;J. Am. Coll. Cardiol.,2002

5. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis;Inaba;Int J Cardiovasc Imaging,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes;Journal of Clinical Medicine;2024-08-25

2. PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?;Current Atherosclerosis Reports;2024-08-16

3. Advancements in risk stratification and management strategies in primary cardiovascular prevention;Atherosclerosis;2024-08

4. Endothelial dysfunction: molecular mechanisms and clinical implications;MedComm;2024-07-22

5. Lipid-lowering Therapy and Coronary Plaque Regression;Journal of Atherosclerosis and Thrombosis;2024